Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy

Cardiovascular diseases (CVD) have emerged as a common and serious complication of cancer treatment, particularly in patients undergoing cardiotoxic therapies. Over the last few years, the medical community has become increasingly aware of the potential for cardiotoxicity resulting from cancer treat...

Descripción completa

Detalles Bibliográficos
Autor principal: Andreescu, Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688222/
https://www.ncbi.nlm.nih.gov/pubmed/38033434
http://dx.doi.org/10.7759/cureus.49696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688222/
https://www.ncbi.nlm.nih.gov/pubmed/38033434
http://dx.doi.org/10.7759/cureus.49696

Ejemplares similares